Table 1.
Patients demographic.
| Patient ID | Sex | Age | Hist | FT3 | FT4 | TSH | TRAB | TPO | TSAB | EUT (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| GD | ||||||||||
| GD1 | M | 47 | GD | 13.0 | 2.06 | 32 | 2.6 | 8 | ||
| GD2 | F | 71 | GD | 4.7 | 11.4 | 6.83 | 4.7 | <2 | 2.9 | 7 |
| GD3 | F | 23 | GD | 7.1 | 7.84 | <1 | 1,059 | 3.0 | 7 | |
| GD4 | M | 48 | GD | 4.3 | 14.9 | 0.04 | 11.7 | <2 | 2.4 | 4 |
| GD5 | F | 63 | GD | 22.4 | <0.02 | 6.7 | 2.5 | 3 | ||
| GD6 | F | 39 | GD | 5.6 | 17.5 | <0.02 | 3.1 | 6 | ||
| GD7 | F | 52 | GD | 5.6 | 9.3 | 0.29 | 15.8 | >1,000 | 3.0 | 21 |
| GD8 | F | 38 | GD | 13.2 | 0.43 | 2.9 | 12 | |||
| GD9 | M | 31 | GD | 12.3 | 2.34 | 3 | ||||
| GD10 | F | 57 | TMNG | 4.5 | 12.9 | <0.02 | 19.3 | 648 | 2.7 | 10 |
| GD11 | F | 27 | TMNG | 4.6 | 14.1 | <0.02 | 3.3 | 6 | ||
| Toxic MNG | ||||||||||
| MNG1 | F | 43 | TMNG | 5.3 | 17.8 | <0.02 | 1.6 | 2 | ||
| MNG2 | M | 76 | TMNG | 13.0 | 0.1 | <1 | 1.1 | 9 | ||
| MNG3 | F | 61 | TMNG | 14.3 | 0.92 | 50 | 1.2 | 20 | ||
| MNG4 | F | 70 | TA | 13.0 | 1.22 | <1 | 12.5 | 1.2 | 16 | |
| MNG5 | M | 61 | TMNG | 13.5 | 0.21 | 1.2 | 21 | |||
| MNG6 | M | 89 | TMNG | 14.1 | 0.25 | 1.1 | 9 | |||
| Control | ||||||||||
| CO1 | F | 21 | CN | 13.5 | 1.56 | 1.4 | ||||
| CO2 | F | 78 | HN | 13.0 | 3.26 | 1.1 | ||||
| CO3 | F | 46 | BC | 12.6 | 1.46 | 1.2 | ||||
| CO4 | F | 71 | EMNG | 16.7 | 1.79 | 1.3 | ||||
| CO5 | M | 50 | EMNG | 12.2 | 0.61 | 1.1 | ||||
| CO6 | F | 27 | EMNG | 14.0 | 2.58 | <2 | 1.2 | |||
| CO7 | F | 78 | EMNG | 13.7 | 0.11 | 1.8 | ||||
| CO8 | F | 27 | EMNG | 14.6 | 1.09 | 1.2 | ||||
| CO9 | F | 61 | EMNG | 14.0 | 0.57 | <2 | 1.3 | |||
| CO10 | M | 45 | EMNG | 16.5 | 0.83 | <2 | 1.4 | |||
| CO11 | F | 71 | EMNG | 13.0 | 0.65 | 300 | 1.2 | |||
F, female; M, male; Hist, histology; EUT, euthyroid duration; GD, Graves’ disease; TMNG, toxic multinodular goiter; EMNG, euthyroid multinodular goiter; TA, toxic adenoma; CN, colloid nodules; HN, hyperplastic nodules; BC, benign cyst.
Normal reference: FT3 (2.6–5.7 pmol/l), FT4 (9.2–22 pmol/l), thyroid-stimulating hormone (TSH) (0.30–4.40 mU/l), thyroid receptor antibodies (TRAB; <1 negative, 1–1.4, borderline >1.4 U/l positive), thyroid peroxidase antibodies (TPO) (<32 kU/l is negative), and thyroid-stimulating antibodies (TSAB; stimulation index 97.5th SD of normal <1.4 is negative).